Episode 50 – Marc de Garidel & Sylvie Grégoire – CEO & Chair of Abivax

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.

In this special follow-up episode, I’m rejoined by Marc de Garidel, CEO of Abivax, after our hugely popular conversation last year—recorded just after their record-breaking NASDAQ IPO. That episode gave us a look into Marc’s incredible career, the company’s bold vision, and how they were gearing up to become a major player in inflammatory diseases.

This time, he’s joined by Sylvie Grégoire, Chair of the Abivax Board—a hugely respected industry leader with decades of global biotech and pharma experience.

Together, we dive into what’s changed in the past year, how they’re navigating today’s biotech climate, and what’s next for Abivax as they continue to push forward in ulcerative colitis and beyond.

Two powerhouse leaders. One big conversation.

Enjoy and stay tuned.